Pre-post comparison of study variables. by Felipe Agudelo-Hernández (20790521)

“…</p><p>Results</p><p>Statistically significant improvements were observed in human rights understanding, reduced stigmatizing attitudes toward mental health and decreased authoritarianism. …”

Predicted <i>cis</i>-acting elements in <i>DpAP2</i> promoter. by Lingru Ruan (18995544)

Subjects:

Schematic diagram of the molecular mechanism by which TRIM37 improves MS by stabilizing PEX5 through monoubiquitination. by Lai Jiang (2401513)

Subjects:

Fig 5 - by Lingru Ruan (18995544)

Subjects:

Fig 2 - by Lingru Ruan (18995544)

Subjects:

RTA408 inhibits the mitophagy pathway. by Hongmei Qian (538647)

Subjects:

Fig 4 - by Lingru Ruan (18995544)

Subjects:

RTA408 inhibits excessive autophagy in the eyes of glaucomatous mice. by Hongmei Qian (538647)

Subjects:

Necropsy lesions of deceased chicks from group B, lesions are presented in yellow arrows. by Oumayma Arbani (21001472)

Subjects:

The presence of the gRNA targeting <i>OPG147</i> has no effect on transcription of viral entry and early genes. by Xue-Mei Yi (18851202)

RTA408 promotes Nrf2 expression. by Hongmei Qian (538647)

Subjects:

Non-enzymatic antioxidants in hemolymph of honey bee workers. by Agnieszka Murawska (11021928)

Subjects:

Enzymes activity in hemolymph of honey bee workers. by Agnieszka Murawska (11021928)

Subjects:

Summary of all significant gene enrichment terms for every condition (as combination of sample type and timepoint). by Dominykas Murza (22676289)

ELISA of the key proteins. by Du Leng (20421711)

“…KEGG pathway analysis showed a significant enrichment of DEPs in PI3K-Akt pathway and focal adhesion. …”

Overexpression <i>TRIM37</i> inhibits inflammatory infiltration and alleviates demyelination in EAE model mice. by Lai Jiang (2401513)

Subjects:

DataSheet1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

“…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”

DataSheet3_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

“…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”

DataSheet2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

“…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”

DataSheet4_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

“…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”